Search
MoonLake Immunotherapeutics
MLTXAdd to Watchlist
18.440USD
-0.550-2.90%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.52BMarket Cap
LossP/E TTM
MLTX Financials
See MoonLake Immunotherapeutics's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
MoonLake Immunotherapeutics Earnings Date
Latest Release
May 11, 2026
EPS / Forecast
-0.98/-0.89
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-3.53
-86.40%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its current assets were 421.69M, with a year-on-year change of -11.09.
What are the total assets of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its total assets of MoonLake Immunotherapeutics were 424.43M, with a year-on-year change of -11.19.
What are the total liabilities of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its total liabilities of MoonLake Immunotherapeutics were 119.95M, with a year-on-year change of 388.76.
What is the total equity of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its total equity of MoonLake Immunotherapeutics was 304.48M, with a year-on-year change of -32.84.
What is the net operating income of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its net operating income of MoonLake Immunotherapeutics was -244.83M, with a year-on-year change of -71.10.
What is the net investment of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its net investment of MoonLake Immunotherapeutics was 202.99M, with a year-on-year change of 198.73.
What is the net financing of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its net financing of MoonLake Immunotherapeutics was 146.00M, with a year-on-year change of 184.53.
What is the Earnings Per Share (EPS) of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its Earnings Per Share (EPS) was -3.53, with a year-on-year change of -86.40.
What is the net income of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its net income was -227.32M, with a year-on-year change of -91.13.
What is the Return on Equity (ROE) of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its Return on Equity (ROE) was -60.51, with a year-on-year change of -139.77.
What is the Return on Assets (ROA) of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its Return on Assets (ROA) was -51.05, with a year-on-year change of -111.46.
What is the operating profit of MoonLake Immunotherapeutics?
According to MoonLake Immunotherapeutics's FY2025 earnings report, its operating profit was -244.83M, with a year-on-year change of -71.10.